The frequency of type 2 CD8+ T cells is increased in peripheral blood from patients with psoriasis vulgaris. 2003

Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan. hifukajimu@derma.m.kanazawa-u.ac.jp

Studies have suggested that psoriasis vulgaris is mediated by type 1 T cells. In this study, we examined both chemokine receptor expression and intracellular cytokine production by circulating T cells to check the type 1/type 2 balance in psoriasis. CCR4+ and CXCR3- T cells predominantly produced interleukin-4 and interferon-gamma, respectively. The frequency of interferon-gamma-producing cells and that of CXCR3+ cells in circulating CD4+ T cells were similar for psoriatic patients and healthy control subjects. By contrast, the frequency of CCR4+CD8+ T cells and CCR4/CXCR3 ratio in circulating CD8- T cells were significantly higher in psoriatic patients than in healthy control subjects. Analysis of intracellular cytokine production also indicated relative increase of type 2 CD8+ T (Tc2) cells in peripheral blood from psoriatic patients. The frequency of circulating Tc2 cells directly correlated with Psoriasis Area and Severity Index. Immunohistochemical analysis showed that not only CXCR3+CD8+ T cells but also a similar number of CCR4+CD8+ T cells infiltrated the psoriatic epidermis and dermis. Our findings suggest an increase in Tc2 cell number in blood from psoriatic patients, and the association of Tc2 cells with inflammation in psoriasis.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
January 2021, Immunology letters,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
January 1994, Muscle & nerve,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
March 2018, Archives of dermatological research,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
June 2001, The Journal of rheumatology,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
September 1980, The Journal of investigative dermatology,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
June 2008, Rheumatology (Oxford, England),
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
August 2019, Oncology letters,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
April 2021, Postepy dermatologii i alergologii,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
April 2013, Journal of dermatological science,
Makoto Inaoki, and Shinichi Sato, and Fumiaki Shirasaki, and Naofumi Mukaida, and Kazuhiko Takehara
April 2002, The Journal of dermatology,
Copied contents to your clipboard!